Another study suggests that a telehealth system could help objectively monitor dose adherence.
Sourced through Scoop.it from: www.neurologyadvisor.com
One of the challenges with oral DMTs for #MS is that they require precision timing to ensure there is a constant/steady supply of the drug in the patient’s system.
A larger issue, however, may be the psychological aspect of oral DMTs, which means that the patient has to confront living with #MS at least once or twice daily, rather than once every 4 weeks, every 2 weeks, weekly, thrice weekly, or daily. It’s this that may be responsible for the lack of adherence.
A key question is how do we mitigate the psychological aspects and help to foster greater adherence if these medications are to be as effective as they can be?